Belgium Patient Support Programs (PSP) Market Report 2022 to 2030

Belgium Patient Support Programs (PSP) Market Analysis

$ 3999

Belgium's Patient Support Programs (PSP) market is expected to grow from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the year 2022-2030 mainly due to the increasing demand for patient-centric care and individualized treatment option in Belgium. The Belgium Patient Support Programs (PSP) market is segmented by functionality outlook, therapeutic outlook, application outlook, and end user. Some of the major PSP operators in the Belgium Patient Support Programs (PSP) market are Novellas Healthcare, Ashfield Engage, and Remedus.

ID: IN10BEHS014 CATEGORY: Healthcare Services GEOGRAPHY: Belgium AUTHOR: Parul Choudhary

Buy Now

Belgium Patient Support Programs (PSP) Market Executive Analysis

Belgium's Patient Support Programs (PSP) market size is at around $xx Bn in 2022 and is projected to reach $xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period. With a health budget of 10.7% of GDP in 2019, Belgium ranks among the top ten EU nations in terms of health spending. Belgians have overall good health and a long life expectancy. This is partially attributable to the population's easy access to a wide range of high-quality health services.

A $34.33 Bn health budget for 2022 was authorized by the Belgian federal government. This is a rise of $1.50 Bn from the budget for 2021. The overall social security budget in Belgium includes a number of social welfare initiatives in addition to the health budget. With a total of $19.46 Bn set aside, hospitals receive the majority of the funding from the health budget. Pharmaceutical expenditure, which includes the price of medications and vaccines, is included in the health budget at $5.45 Bn. The health budget allocates $235.25 Mn for initiatives aimed at preventing disease and promoting health, with the goal of enhancing public health and lowering healthcare expenses. Overall, Belgium's health budget for 2022 reflects the country's commitment to delivering high-quality healthcare to its citizens as well as investing in programs and services that encourage better health outcomes and a more efficient healthcare system.

PSPs are created to offer treatment-focused help to patients who are given a medical product on prescription. PSPs are primarily created in Belgium by pharmaceutical firms with the assistance and knowledge of medical specialists. In Belgium, there are a number of disease-specific PSPs that are intended to offer assistance and resources to patients with particular medical conditions like cancer, diabetes, and cardiovascular disease. These initiatives might offer training, resources for self-management, and access to support networks. Telehealth programs, which link patients with healthcare providers and tools using digital technologies, are growing in popularity in Belgium. These programs might provide access to educational methods, remote monitoring, and virtual consultations.

Market Dynamics

Market Growth Drivers

In the Belgian healthcare system, there is a growing trend toward patient-centered care, which emphasizes delivering care that is tailored to the needs and preferences of individual patients. PSPs are a crucial component of this strategy because they offer patients individualized assistance and resources, which stimulates the Belgium PSP market growth.

Market Restraints

PSP delivery in Belgium is not currently standardized. This may make it challenging for people to get access to the programs they require and may reduce the programs’ efficacy. Despite evidence that PSPs can improve patient outcomes, Belgium's healthcare practitioners have only recently begun to use them. This may be caused by a number of things, such as a lack of funding or program implementation expertise. These factors are responsible for impeding the Belgium PSP market growth.

Major Patient Support Programs in Belgium

Patient Support Programs	Focus Area	Pharma Sponsor
FibriCoach	Atrial Fibrillation	Bristol Myers Squibb
Lysomed	Lysosomal storage diseases	Sanofi
Abbvie Care Program	Chronic Inflammatory Diseases	Abbvie
Rheumatoid Arthritis LIGA vzw	Rheumatoid Arthritis	Pfizer
Crohn & Colitis ulcerosa Vereniging vzw (Crohn's & Ulcerative Colitis Association vzw)	Chronic Inflammatory Bowel Disease	Pfizer
UCB Cares	Treatment Guidance	UCB
MyRealWorld MG	Myasthenia Gravis	Argenx
'Because there is more to do'	Patient feedback forum	Bristol Myers Squibb

Top PSP Operators in Belgium

Novellas Healthcare- Novellas Healthcare is an international partner of the life sciences industry specializing in staffing solutions and patient support programs
Ashfield Engage- Ashfield Engage provides next-generation patient engagement programs, built on behavioral science, patient-centric technology, and collaborations
Remedus- It offers a mobile health platform with all necessary criteria for home treatment, as well as customized care and follow-up at home, in order to provide prompt service and keep patients in charge of their recommended course of action
Marti Farm- Marti Farm rises up to the challenge of poor patient adherence and non-adherence, by giving the patients access and support they need while ensuring healthcare utilization
Mobius- Mobius provide Value-Based Healthcare, Patient Support Programs (PSP), PROMS, CROMS & PREMS, Resilient Supply Chains, etc. which helps organizations to get the added value of the latest concepts in the healthcare landscape

Healthcare Policies and Regulatory Landscape

In Belgium, PSPs are mainly developed by pharmaceutical companies and developed with the support and expertise of healthcare professionals. The Federal Agency for Medicines and Health Products (FAMHP) registered an increase in the use of Patient Support programs (PSPs) in Belgium. According to FAMHP, while setting up a PSP, there should be no direct contact between the pharma company and the patient, and the PSP should thus be implemented via the patients’ healthcare professional. The PSP should not constitute an inducement for healthcare professionals to recommend, prescribe, purchase, sell, supply, or administer medicinal products.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Patient Support Programs Market Segmentation

By Functionality Outlook

Communication
Health Tracking & Insights
Billing & Payments
Administrative
Patient Education
Others

By Therapeutic Area Outlook

Health & Wellness
Chronic Disease Management
Others

By Application Outlook

Population Health Management
Outpatient Health Management
In-patient Health Management
Others

By End-user

Payers
Providers
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.